Gregoire Emilien, Pirotte Benoit François, Moerman Filip, Altdorfer Antoine, Gaspard Laura, Firre Eric, Moonen Martial, Darcis Gilles
Department of Internal Medicine and Infectious Diseases, Centre Hospitalier Régional (CHR), Liege, Belgium.
Department of Internal Medicine and Infectious Diseases, Centre Hospitalier Universitaire (CHU), Liege, Belgium.
Acta Clin Belg. 2022 Jun;77(3):679-684. doi: 10.1080/17843286.2021.1919845. Epub 2021 Apr 22.
Opportunistic infections (OI) are common in patients with acquired immunodeficiency syndrome (AIDS). Cryptococcus neoformans and Mycobacterium avium complex (MAC) are frequently responsible of such infections. However, concurrent infection with these two pathogens is uncommon and underreported in the literature.
We describe the case of a 28-year-old Caucasian Belgian patient with no travel history, who presented with low-grade fever, headache and wasting syndrome. He was diagnosed with human immunodeficiency virus (HIV) infection at AIDS stage, with a HIV viral load of 506,000 viral copies/mL and a CD4 + T-cells count of 10 cells/µL. Diagnosis of disseminated Cryptococcus neoformans infection was made by positive serum cryptococcal antigen and positive culture for Cryptococcus neoformans in blood and in cerebrospinal fluid. Diagnosis of disseminated Mycobacterium avium complex infection was made by positive culture on a biopsy of a mediastinal lymph node. With adequate anti-retroviral therapy (ART) and treatment of these OIs, the patient recovered well and had a good clinical evolution.
To our knowledge, this is the second case of coexistence of these two dangerous OIs reported in the post ART era. Clinicians should be aware that such co-infections still happen in high-income countries, in patients with severe immunodeficiency. Early detection and treatment of HIV is of paramount importance to prevent AIDS and its complications. We highlight the importance of thoroughly excluding all opportunistic infections in patients with newly diagnosed AIDS. ABC: abacavir; AIDS: acquired immunodeficiency syndrome; AFB: acid-fast bacilli; ART: antiretroviral therapy; CM: cryptococcal meningitis; CrAg: cryptococcal antigen; CSF: cerebrospinal fluid; CT: computed tomography; EACS: European AIDS Clinical Society; FTC: emtricitabine; HIC: high-income countries; HIV: human immunodeficiency virus; HIV-VL: HIV-viral load; ICP: intracranial pressure; IRIS: immune reconstitution inflammatory syndrome; MAC: Mycobacterium avium complex; MRI: magnetic resonance imaging; MSM: man who has sex with men; NR: normal range; OD: omne in die = once daily; OI: opportunistic infection; RAL: raltegravir; TAF: tenofovir alafenamide fumarate.
机会性感染(OI)在获得性免疫缺陷综合征(AIDS)患者中很常见。新型隐球菌和鸟分枝杆菌复合体(MAC)常导致此类感染。然而,这两种病原体的合并感染并不常见,且文献报道较少。
我们描述了一名28岁无旅行史的比利时白人患者的病例,该患者出现低热、头痛和消瘦综合征。他在艾滋病期被诊断为人类免疫缺陷病毒(HIV)感染,HIV病毒载量为506,000拷贝/mL,CD4 + T细胞计数为10个细胞/µL。血清隐球菌抗原阳性以及血液和脑脊液中新型隐球菌培养阳性,确诊为播散性新型隐球菌感染。纵隔淋巴结活检培养阳性,确诊为播散性鸟分枝杆菌复合体感染。通过适当的抗逆转录病毒疗法(ART)和对这些机会性感染的治疗,患者恢复良好且临床进展良好。
据我们所知,这是ART时代后报道的这两种危险机会性感染共存的第二例病例。临床医生应意识到,在高收入国家,严重免疫缺陷患者中仍会发生此类合并感染。早期检测和治疗HIV对于预防艾滋病及其并发症至关重要。我们强调在新诊断的艾滋病患者中彻底排除所有机会性感染的重要性。ABC:阿巴卡韦;AIDS:获得性免疫缺陷综合征;AFB:抗酸杆菌;ART:抗逆转录病毒疗法;CM:隐球菌性脑膜炎;CrAg:隐球菌抗原;CSF:脑脊液;CT:计算机断层扫描;EACS:欧洲艾滋病临床学会;FTC:恩曲他滨;HIC:高收入国家;HIV:人类免疫缺陷病毒;HIV-VL:HIV病毒载量;ICP:颅内压;IRIS:免疫重建炎症综合征;MAC:鸟分枝杆菌复合体;MRI:磁共振成像;MSM:男男性行为者;NR:正常范围;OD:每日一次;OI:机会性感染;RAL:拉替拉韦;TAF:替诺福韦艾拉酚胺富马酸盐